PAD4 citrullination has been associated with RA (151) and anti-citrullinated protein antibodies (ACPA) have been identified in 50–70% of RA patients at diagnosis, with a specificity over 90%. The gene discussed is PRTN3; the disease is rheumatoid arthritis.